These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 15089990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.
    Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Böcker D, Wichter T, Mika Y, Ben-Haim S, Burkhoff D, Wolzt M, Schmidinger H.
    Eur Heart J; 2004 Apr; 25(8):650-5. PubMed ID: 15084369
    [Abstract] [Full Text] [Related]

  • 3. Cardiac contractility modulation by non-excitatory electrical currents. The new frontier for electrical therapy of heart failure.
    Augello G, Santinelli V, Vicedomini G, Mazzone P, Gulletta S, Maggi F, Mika Y, Chierchia G, Pappone C.
    Ital Heart J; 2004 Jun; 5 Suppl 6():68S-75S. PubMed ID: 15185918
    [Abstract] [Full Text] [Related]

  • 4. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
    Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco EJ, Sharov VG, Goldstein S, Ben-Haim S, Sabbah HN.
    J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, Misier AR, Curnis A, Böcker D, Remppis A, Kautzner J, Stühlinger M, Leclerq C, Táborsky M, Frigerio M, Parides M, Burkhoff D, Hindricks G.
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
    Abraham WT, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Kadish A, FIX-HF-5 Investigators and Coordinators.
    J Card Fail; 2011 Sep; 17(9):710-7. PubMed ID: 21872139
    [Abstract] [Full Text] [Related]

  • 8. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A, Mijic D, Schiedat F, Bogossian H, Mügge A, Rousso B, Lemke B.
    Cardiol J; 2016 Sep; 23(1):114-9. PubMed ID: 26503077
    [Abstract] [Full Text] [Related]

  • 9. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
    Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC, Mika Y, Rousso B, Burkhoff D, Ben-Haim S, Sabbah HN.
    J Am Coll Cardiol; 2007 May 29; 49(21):2120-8. PubMed ID: 17531662
    [Abstract] [Full Text] [Related]

  • 10. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.
    J Med Assoc Thai; 2007 Jul 29; 90(7):1458-66. PubMed ID: 17710992
    [Abstract] [Full Text] [Related]

  • 11. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
    Butter C, Wellnhofer E, Schlegl M, Winbeck G, Fleck E, Sabbah HN.
    J Card Fail; 2007 Mar 29; 13(2):137-42. PubMed ID: 17395055
    [Abstract] [Full Text] [Related]

  • 12. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.
    Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447
    [Abstract] [Full Text] [Related]

  • 13. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
    Neelagaru SB, Sanchez JE, Lau SK, Greenberg SM, Raval NY, Worley S, Kalman J, Merliss AD, Krueger S, Wood M, Wish M, Burkhoff D, Nademanee K.
    Heart Rhythm; 2006 Oct 01; 3(10):1140-7. PubMed ID: 17018340
    [Abstract] [Full Text] [Related]

  • 14. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.
    J Card Fail; 2008 Feb 01; 14(1):9-18. PubMed ID: 18226768
    [Abstract] [Full Text] [Related]

  • 15. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S, Schneider R, Rudic B, Liebe V, Stach K, Schimpf R, Borggrefe M, Kuschyk J.
    Europace; 2014 Aug 01; 16(8):1205-9. PubMed ID: 24706089
    [Abstract] [Full Text] [Related]

  • 16. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.
    Am J Cardiol; 2006 Jul 15; 98(2):230-5. PubMed ID: 16828599
    [Abstract] [Full Text] [Related]

  • 17. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H, Behrens S, Eisermann C.
    Europace; 2008 Dec 15; 10(12):1375-80. PubMed ID: 18776196
    [Abstract] [Full Text] [Related]

  • 18. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C, Gold M, Abraham WT, Daubert JC, REVERSE Study Group.
    Am Heart J; 2006 Feb 15; 151(2):288-94. PubMed ID: 16442890
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A, InSync/InSync ICD Italian Registry Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):1007-12. PubMed ID: 17826388
    [Abstract] [Full Text] [Related]

  • 20. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group.
    Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.